Pure Global

The Binding Site Optilite C3c Kit - Taiwan Registration c3f4c34ac193e6d81c1c88146ba15685

Access comprehensive regulatory information for The Binding Site Optilite C3c Kit in Taiwan's medical device market through Pure Global AI's free database. This Risk Class 2 medical device is registered under number c3f4c34ac193e6d81c1c88146ba15685 and manufactured by THE BINDING SITE GROUP LTD. The authorized representative in Taiwan is EVERLIGHT BIOTECH(TAIWAN) CO., LTD..

This page provides complete technical specifications, regulatory compliance details. Pure Global AI offers free access to 89,000+ Taiwan medical device registrations, helping global MedTech companies navigate Taiwan FDA regulations, identify competitors, and discover partnership opportunities efficiently.

Free Database
Powered by Pure Global AI
89,000+ Devices
c3f4c34ac193e6d81c1c88146ba15685
Registration Details
Taiwan FDA Registration: c3f4c34ac193e6d81c1c88146ba15685
Pure Global
DJ Fang

DJ Fang

MedTech Regulatory Expert

Need help with 30+ markets registration?

Pricing

Device Details

The Binding Site Optilite C3c Kit
TW: ้‚ฆ่ฟชๆ–ฏๆญๆ™ฎ็พ…่ฃœ้ซ”C3cๅˆ†ๆžๅฅ—็ต„
Risk Class 2
MD

Registration Details

c3f4c34ac193e6d81c1c88146ba15685

Ministry of Health Medical Device Import No. 032192

DHA05603219203

Company Information

United Kingdom

Product Details

This product is used with the Binding Site Plite analyzer for the quantitative determination of complement C3c in vitro, and is suitable for plasma of serum, lithium heparin salt or EDTA anticoagulant.

C Immunology and microbiology devices

C5240 Complement Component Immunoassay System

Imported from abroad

Dates and Status

Feb 26, 2019

Feb 26, 2024